Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab
I discuss the safety and efficacy of the newest Alzheimer's drug treatments, aducanumab (Aduhelm) and...
A micromort as a unit of comparing and communicating risk to patients equivalent to a one-in-a-million chance of dying.
Watch Latest Video